Skip to main content

Are you Central Compounding Center - Durham? Claim this listing to update your information and add verification.

Claim listing
503A Pharmacy
Verified listing

Verified

Central Compounding Center - Durham

North Carolina, United States
4.789 reviewsGoogle

Central Compounding Center South is a PCAB-accredited compounding pharmacy in Durham, NC that creates customized medications including hormone replacement therapy for men and women, low-dose naltrexone, weight management compounds, and veterinary medications. The pharmacy works with patients' doctors and practitioners to prepare individualized formulations and also offers salivary hormone testing and nutritional supplements. They serve individuals and pets requiring specialized compounded therapies and operate Monday-Friday, 9am-5:30pm with a lunch break from 12:30-1pm.

Provider Details

503A Compounding Pharmacy

Prescriptions are required. Compounds are prepared to order for individual patients and cannot be sold in bulk without a physician order.

Coverage

Country
United States
State
North Carolina
Telehealth
Not available
Regions Served
United States

Compliance

Verified Listing
Yes
Compliance Type
503A Compounding

Verification & FDA Records

Verified listing· · 503A Compounding Pharmacy

Report an error

Central Compounding Center - Durham

Use this form to flag incorrect data, outdated information, or a misattributed finding. Our team reviews every report.

Related providers

Track this provider

Know when Central Compounding Center - Durham changes.

Get an email when their verification status, reviews, or peptide list is updated.

Listed on PeptideBase badge

Add this badge to your website

Profile last updated

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.

Free Guide

The Peptide Research Digest

Get our free provider vetting guide — plus weekly research briefings on peptide sourcing, COA verification, and clinical developments.

No spam.